US Chemical Technologies, Inc. filed a Form D with the Securities and Exchange Commission on 2026-01-23.
US Chemical Technologies, Inc. filed a Form D notice of an exempt securities offering with the SEC on January 23, 2026. The filing reports $30M sold. Its industry group is Other Technology. It names Daniel DePaoli (Executive Officer, Director), David Glickman (Executive Officer, Director), Alan Freedman (Director) (SEC Form D, January 23, 2026).
Is this your company?
Sell to companies like US Chemical Technologies, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2026-01-23 · the record
Pitching, partnering or investing alongside them? See who really runs and owns US Chemical Technologies, Inc.
Free to see. No signup.
More on the people and the money behind US Chemical Technologies, Inc., from the filings we hold.
Other Technology raises by companies based in District of Columbia, filed within 90 days of this one, largest first.
Get an email when US Chemical Technologies, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when US Chemical Technologies, Inc. raises, hires or launches. No email unless you switch it on.
Watch US Chemical Technologies, Inc. →Get the full cited report on US Chemical Technologies, Inc.
What the filing shows about US Chemical Technologies, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on US Chemical Technologies, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives US Chemical Technologies, Inc.'s address as 3506 Connecticut Avenue, Nw, Washington, DC 20008.
Saved here on this device in the meantime, so nothing is lost either way.
Full funding history for US Chemical Technologies, Inc. →
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Order the Full Report on US Chemical Technologies, Inc. See pricing
US Chemical Technologies, Inc. is a registered filer with the SEC (CIK 2070703) and has filed since 2025-06-10. 3 filings are on record, the latest on 2026-07-07.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
US Chemical Technologies, Inc.'s Form D of 2026-01-23 names Daniel DePaoli, David Glickman, Alan Freedman and 1 more as its officers, directors or promoters.
Its new offerings report $71M sold across 3 offerings, as its own filings state.
Each marker is one filing. The larger marker is the filing this page is about.
Trailing twelve months. 3844 filings in Other Technology, totalled by week. The dot is this raise, $30M, on the same scale — one filing against the whole group's total, so it sits low by construction.
Daniel DePaoli is named as Executive Officer and Director on the Form D that US Chemical Technologies, Inc. filed with the SEC on 23 January 2026, one of 4 people that filing names.
David Glickman is named as Executive Officer and Director on the Form D that US Chemical Technologies, Inc. filed with the SEC on 23 January 2026, one of 4 people that filing names.
Alan Freedman is named as Director on the Form D that US Chemical Technologies, Inc. filed with the SEC on 23 January 2026, one of 4 people that filing names.
Dayna Grayson is named as Director on the Form D that US Chemical Technologies, Inc. filed with the SEC on 23 January 2026, one of 4 people that filing names.
4 people named on the filing — 2 holding an executive role and 2 as directors only.
Named as of the 2026-01-23 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about US Chemical Technologies, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on US Chemical Technologies, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on US Chemical Technologies, Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist US Chemical Technologies, Inc.You get an alert in MentionFox the next time this company shows up.
If you're behind US Chemical Technologies, Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for US Chemical Technologies, Inc.. With no account yet, you sign up free and land on the result.
On these lists: AI and software raises in Washington, DC
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/us-chemical-technologies-inc-form-d-26000004